PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Leaf extracts showed antibacterial effects against Bacillus subtilis, Escherichia coli, Proteus vulgaris, and Staphylococcus aureus [PMID:27074391]
Leaf extract (rich in scopoletin and epicatechin) reduced joint cartilage degradation and inflammation in pre-clinical animal studies [PMID:31353568]
M. citrifolia has demonstrated antitumor, antiproliferative, pro-apoptotic, antiangiogenesis, antimigratory, anti-inflammatory, and immunomodulatory activities in clinical and preclinical studies [PMID:36448674]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 17286240 (2007) — Morinda citrifolia (Noni) fruit--phytochemistry, pharmacology, safety. · Planta medica
- 2.PMID: 36448674 (2022) — Efficacy and Safety of Morinda citrifolia L. (Noni) as a Potential Anticancer Agent. · Integrative cancer therapies
- 3.PMID: 28587078 (2017) — Morinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction. · Nutrients
- 4.PMID: 26404212 (2015) — Anti-Diabetic Potential of Noni: The Yin and the Yang. · Molecules (Basel, Switzerland)
- 5.PMID: 33336991 (2019) — Properties and Applications of Morinda citrifolia (Noni): A Review. · Comprehensive reviews in food science and food safety